Regulus Therapeutics Inc (NASDAQ:RGLS) Has Recovered -15.21% To Date, But An Additional -189.31% Is Possible.
In last trading session, Regulus Therapeutics Inc (NASDAQ:RGLS) saw 0.3 million shares changing hands with its beta currently measuring 1.48. Company’s recent per share price